Analysen zu Novartis AG
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Kaufen | DZ BANK | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 10.07.24 | Novartis Buy | Deutsche Bank AG | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Deutsche Bank AG | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | Novartis Underweight | Barclays Capital | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.06.24 | Novartis Buy | Deutsche Bank AG | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.05.24 | Novartis Buy | UBS AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 10.04.24 | Novartis Buy | UBS AG |
Aktuelle Aktienanalysen
| 01.04.26 | Enel Overweight | JP Morgan Chase & Co. | |
| 01.04.26 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 01.04.26 | E.ON Overweight | JP Morgan Chase & Co. | |
| 01.04.26 | RWE Overweight | JP Morgan Chase & Co. | |
| 01.04.26 | Orsted Equal Weight | Barclays Capital | |
| 31.03.26 | SMA Solar Buy | Jefferies & Company Inc. | |
| 31.03.26 | Ferrari Outperform | RBC Capital Markets | |
| 31.03.26 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 31.03.26 | adidas Buy | Jefferies & Company Inc. | |
| 31.03.26 | Ferrari Buy | Jefferies & Company Inc. | |
| 31.03.26 | SUSS MicroTec Verkaufen | DZ BANK | |
| 31.03.26 | Daimler Truck Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | AUMOVIO Hold | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Outperform | Bernstein Research | |
| 31.03.26 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 31.03.26 | Hermès Outperform | RBC Capital Markets | |
| 31.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 31.03.26 | ams buy | Baader Bank | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Beiersdorf Hold | Jefferies & Company Inc. | |
| 31.03.26 | Philips Market-Perform | Bernstein Research | |
| 31.03.26 | Eni Buy | UBS AG | |
| 31.03.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 31.03.26 | CTS Eventim Buy | Deutsche Bank AG | |
| 31.03.26 | Porsche Automobil Halten | DZ BANK | |
| 31.03.26 | Unilever Underperform | RBC Capital Markets | |
| 31.03.26 | SUSS MicroTec Buy | Warburg Research | |
| 31.03.26 | JOST Werke Buy | Warburg Research | |
| 31.03.26 | Akzo Nobel Hold | Deutsche Bank AG | |
| 31.03.26 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 31.03.26 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Sixt Buy | Deutsche Bank AG | |
| 31.03.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 31.03.26 | Medios Buy | Deutsche Bank AG | |
| 31.03.26 | CANCOM Buy | Deutsche Bank AG | |
| 31.03.26 | K+S Sell | Deutsche Bank AG | |
| 31.03.26 | SUSS MicroTec Buy | Deutsche Bank AG | |
| 31.03.26 | Inditex Buy | Deutsche Bank AG | |
| 31.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 31.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 31.03.26 | Saint-Gobain Neutral | Goldman Sachs Group Inc. | |
| 31.03.26 | Heidelberg Materials Buy | Goldman Sachs Group Inc. | |
| 31.03.26 | FRIEDRICH VORWERK Underperform | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Deutsche Börse Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | ASML NV Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.